TMEM106B Fibrils from FTLD Patients and Healthy Controls
ACS Chemical Neuroscience · 2023
DOI: 10.1021/acschemneuro.3c00482 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von James D Greenwood und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Colorado, Boulder, Colorado 80309, United States. Hauptthemen laut MEDLINE: Frontotemporal Dementia, Frontotemporal Lobar Degeneration. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institute on Aging.
Abstract (Originalsprache)
Recent studies involving four research teams have revealed that amyloid fibrils in FTLD-TDP patients and cognitively healthy individuals primarily consist of TMEM106B, a protein previously identified as a risk factor for FTLD-TDP. Through cryogenic electron microscopy, the studies identified various protofilament structures of TMEM106B fibrils from individuals with several neurodegenerative diseases. These findings raise new questions and opportunities for future research, as they suggest that TMEM106B plays a central role in FTLD pathology. These discoveries also prompt the need for the development of specific antibodies for fibrillar TMEM106B and necessitate further investigation of the potential mechanistic link between TMEM106B and other filamentous aggregates. The power of cryo-EM techniques is underscored in these unexpected findings and may be a vital tool for gaining further molecular insights into neurodegenerative diseases characterized by amyloid deposits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Colorado, Boulder, Colorado 80309, United States.
ORCID-Profile: Maciej A Walczak
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Greenwood, J. D., Powell, W. C., & Walczak, M. A. (2023). TMEM106B Fibrils from FTLD Patients and Healthy Controls. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00482
Vancouver
Greenwood JD, Powell WC, Walczak MA. TMEM106B Fibrils from FTLD Patients and Healthy Controls. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.3c00482
BibTeX
@article{Greenwood2023,
author = {Greenwood, James D and Powell, Wyatt C and Walczak, Maciej A},
title = {TMEM106B Fibrils from FTLD Patients and Healthy Controls},
journal = {ACS Chemical Neuroscience},
year = {2023},
doi = {10.1021/acschemneuro.3c00482}
}
EUVIMED